Search research articles
Contact Us
Filters
Showing results (1-10 of 524) with videos related to
Page
of 53
Sort By:
Seminars in Reproductive Medicine
|
June 8, 2001
Clinical data supporting the importance of vascular LH/hCG receptors of uterine blood vessels
P Toth
Journal of Clinical Lipidology
|
February 5, 2011
Making a case for quantitative assessment of cardiovascular risk
Peter P Toth
The American Journal of Cardiology
|
November 18, 2005
High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies
Peter P Toth
The American Journal of Cardiology
|
September 14, 2016
Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction
Peter P Toth
Postgraduate Medicine
|
January 31, 2009
The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes
Peter P Toth
Endocrinology and Metabolism Clinics of North America
|
February 17, 2009
Novel therapies for increasing serum levels of HDL
Peter P Toth
Current Atherosclerosis Reports
|
December 16, 2006
Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
Peter P Toth
Current Cardiology Reports
|
September 13, 2011
CETP Inhibition: does the future look promising?
Peter P Toth
Postgraduate Medicine
|
April 2, 2014
An update on the benefits and risks of rosuvastatin therapy
Peter P Toth
Vascular Health and Risk Management
|
January 8, 2015
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
Peter P Toth
Page
of 53
Search research articles
Search
Showing results (1-10 of 524) with videos related to
Sort By:
Page
of 53
Seminars in Reproductive Medicine
|
June 8, 2001
Clinical data supporting the importance of vascular LH/hCG receptors of uterine blood vessels
P Toth
Journal of Clinical Lipidology
|
February 5, 2011
Making a case for quantitative assessment of cardiovascular risk
Peter P Toth
The American Journal of Cardiology
|
November 18, 2005
High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies
Peter P Toth
The American Journal of Cardiology
|
September 14, 2016
Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction
Peter P Toth
Postgraduate Medicine
|
January 31, 2009
The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes
Peter P Toth
Endocrinology and Metabolism Clinics of North America
|
February 17, 2009
Novel therapies for increasing serum levels of HDL
Peter P Toth
Current Atherosclerosis Reports
|
December 16, 2006
Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
Peter P Toth
Current Cardiology Reports
|
September 13, 2011
CETP Inhibition: does the future look promising?
Peter P Toth
Postgraduate Medicine
|
April 2, 2014
An update on the benefits and risks of rosuvastatin therapy
Peter P Toth
Vascular Health and Risk Management
|
January 8, 2015
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
Peter P Toth
Page
of 53